44 related articles for article (PubMed ID: 3187978)
1. Interference with the prostaglandin system as a therapeutical concept to protect the myocardium during ischemic stress: experimental studies with inhibition of thromboxane synthesis.
Korb H; Hoeft A; Borowski A; de Vivie ER; Hellige G
Thorac Cardiovasc Surg; 1988 Aug; 36(4):187-93. PubMed ID: 3187978
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of thromboxane synthetase by the imidazole derivative 3-(1H-imidazol-1-yl-methyl)-2-methyl-1H-indole-1-propanoic acid as a novel therapeutic approach to experimental myocardial ischemia.
Korb H; Hoeft A; Wober W; Wolpers HG; Hellige G
Arzneimittelforschung; 1986 Jul; 36(7):1040-4. PubMed ID: 3768069
[TBL] [Abstract][Full Text] [Related]
3. Preservation of myocardium in transient ischemia by the thromboxane synthetase inhibitor UK 38.485.
Hoeft A; Korb H; Böck J; Wolpers HG; Wober W; Hellige G
Res Exp Med (Berl); 1986; 186(1):35-46. PubMed ID: 3961276
[TBL] [Abstract][Full Text] [Related]
4. Improvement of the metabolic and energetic situation of ischemically stressed myocardium by verapamil after experimental coronary artery occlusion.
Korb H; Hoeft A; Baller D; Schräder R; Wolpers HG; Hellige G
Arzneimittelforschung; 1983; 33(11):1546-51. PubMed ID: 6686450
[TBL] [Abstract][Full Text] [Related]
5. [Effects of dichloroacetate in the ischemic heart. Analysis of hemodynamics, myocardial energy metabolism and myocardial pH].
Mizushima M
Hokkaido Igaku Zasshi; 1990 May; 65(3):298-310. PubMed ID: 2379912
[TBL] [Abstract][Full Text] [Related]
6. Effects of a N(6)-disubstituted adenosine derivative on myocardial metabolism and ischemic stress following coronary occlusion.
Kahles H; Junggeburth J; Lick T; Schäfer W; Kochsiek K
Arzneimittelforschung; 1987 Oct; 37(10):1137-40. PubMed ID: 3435585
[TBL] [Abstract][Full Text] [Related]
7. Improved lactate extraction in dogs with coronary artery ligation following administration of a thromboxane synthetase inhibitor.
Eddy LJ; Oei HH; Glenn TM
Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):87-97. PubMed ID: 6682567
[TBL] [Abstract][Full Text] [Related]
8. Effect of a novel thromboxane A2 synthetase inhibitor on ischemia-induced mitochondrial dysfunction in canine hearts.
Ogawa T; Hieda N; Sugiyama S; Toki Y; Ito T; Ogawa K; Satake T; Ozawa T
Arzneimittelforschung; 1988 Feb; 38(2):228-30. PubMed ID: 3370069
[TBL] [Abstract][Full Text] [Related]
9. Influence of the thromboxane synthetase inhibitor HOE 944, prostacyclin and indomethacin on reperfusion arrhythmias, cardiodynamics and metabolism in isolated ischemic rat hearts.
Linz W; Lau HH; Beck G; Schökens BA
Biomed Biochim Acta; 1988; 47(10-11):S23-6. PubMed ID: 3073762
[TBL] [Abstract][Full Text] [Related]
10. Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium.
Farber NE; Pieper GM; Gross GJ
Circulation; 1988 Aug; 78(2):450-61. PubMed ID: 3396181
[TBL] [Abstract][Full Text] [Related]
11. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR
J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129
[TBL] [Abstract][Full Text] [Related]
12. Myocardial salvage by a novel thromboxane A2 synthetase inhibitor in a canine coronary occlusion-reperfusion model.
Toki Y; Hieda N; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T
Arzneimittelforschung; 1988 Feb; 38(2):224-7. PubMed ID: 3370068
[TBL] [Abstract][Full Text] [Related]
13. Changes in myocardial substrate utilisation and protection of ischemic stressed myocardium by oxfenicine [(S)-4-hydroxyphenylglycine].
Korb H; Hoeft A; Hunneman DH; Schraeder R; Wolpers HG; Wober W; Hellige G
Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):70-4. PubMed ID: 6493353
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue.
Huddleston CB; Hammon JW; Wareing TH; Lupinetti FM; Clanton JA; Collins JC; Bender HW
J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591
[TBL] [Abstract][Full Text] [Related]
15. Effect of isoflurane on the extent of myocardial necrosis and on systemic hemodynamics, regional myocardial blood flow, and regional myocardial metabolism in dogs after coronary artery occlusion.
Davis RF; Sidi A
Anesth Analg; 1989 Nov; 69(5):575-86. PubMed ID: 2802193
[TBL] [Abstract][Full Text] [Related]
16. Ischemia-induced alterations in myocardial (Na+ + K+)-ATPase and cardiac glycoside binding.
Beller GA; Conroy J; Smith TW
J Clin Invest; 1976 Feb; 57(2):341-50. PubMed ID: 130383
[TBL] [Abstract][Full Text] [Related]
17. [Effect of nitroglycerin on myocardial function in short-term ischemia].
Moskvitina OA; Trubetskoĭ AV
Biull Eksp Biol Med; 1982 Jul; 94(7):13-5. PubMed ID: 6812664
[TBL] [Abstract][Full Text] [Related]
18. [Changes in PTCA. A model of ischemia in humans].
Prachar H
Acta Med Austriaca Suppl; 1991; 42():1-35. PubMed ID: 1830715
[TBL] [Abstract][Full Text] [Related]
19. Regional myocardial metabolism following acute coronary artery occlusion.
Lang TW; Meerbaum S; Corday E; Costantini C; Rubins S; Cordoba M
Recent Adv Stud Cardiac Struct Metab; 1975; 10():295-305. PubMed ID: 1208983
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of nicorandil in the preservation of myocardium stressed by transient ischemia and its influence on cardiac metabolism during coronary artery occlusion with subsequent reperfusion: a comparison with isosorbide dinitrate.
Korb H; Hoeft A; Hunneman DH; Schraeder R; Wolpers HG; Hellige G
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):440-6. PubMed ID: 3162106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
